Primidone NDC 72888-045

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-045Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0045Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72888-045-01	72888004501	100 TABLET in 1 BOTTLE (72888-045-01)Marketed from Jun 28, 2022
72888-045-05	72888004505	500 TABLET in 1 BOTTLE (72888-045-05)Marketed from Jun 28, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Primidone
Generic name (nonproprietary): primidone
Active ingredients: Primidone — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Advagen Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214896
Marketing start: Jun 28, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 72888-045_48453b30-812c-76c6-e063-6394a90ad9a0SPL ID 48453b30-812c-76c6-e063-6394a90ad9a0SPL set ID b3b94d2e-6a64-45b7-b0cb-0fde689240d8RxCUI 96304, 198150, 328176UNII 13AFD7670QUPC 0372888160016, 0372888046051, 0372888160009, 0372888046013, 0372888045054, 0372888160054, 0372888045016
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888004501 followed by a unit qualifier and the quantity

Package 72888-0045-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 13, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Primidone, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214896

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214896
Product	Strength	Form · route	Labeler	Product NDC
Primidone	Primidone 250 mg/1	TabletOral	Advagen Pharma Limited	72888-046
Primidone	Primidone 125 mg/1	TabletOral	TruPharma LLC.	52817-117
Primidone	Primidone 50 mg/1	TabletOral	NorthStar Rx LLC	72603-609
Primidone	Primidone 250 mg/1	TabletOral	NorthStar Rx LLC	72603-610
Primidone	Primidone 125 mg/1	TabletOral	Advagen Pharma Limited	72888-160